Literature DB >> 35659445

G protein-coupled receptor 30 mediates cell proliferation of goat mammary epithelial cells via MEK/ERK&PI3K/AKT signaling pathway.

Ying Zhao1, Haokun Liu1, Mingzhen Fan1, Yuyang Miao1, Xiaoe Zhao1, Qiang Wei1, Baohua Ma1.   

Abstract

The mammary gland of mammals possesses the specific function of synthesizing, secreting, and delivering milk. Notably, mammary epithelial cells are considered to be central to control the expansion and remodeling of mammary gland into a milk-secretory organ. And the biological function of mammary gland is mainly regulated by the endocrine system, especially for estrogen. G protein-coupled receptor 30 (GPR30), an estrogen membrane receptor, mediates estrogen-induced functions of physiology and pathophysiology. However, the relationship between estrogen/GPR30 signaling and proliferation of goat mammary epithelial cells (gMECs) is still unclear. Herein, estrogen promoted cell proliferation than control, as evidence by upregulation of cell numbers, BrdU-positive cell counts, and cell viability. Of note, these activities were all obviously reduced by treatment with GPR30 antagonist G15, yet GPR30 agonist G1 increased cell proliferation than control. Further, GPR30 silencing inhibited cell proliferation than negative control. This inhibition was accompanied by a G2/M phase arrest and downregulation of cell cycle regulators. Meanwhile, estrogen increased the phosphorylation of ERK1/2 and AKT. Further, the protein level of p-ERK1/2 and p-AKT was enhanced by GPR30 agonist G1 but inhibited by GPR30 antagonist G15 and GPR30 silencing. Importantly, MEK inhibitor and PI3K inhibitor decreased the expression of cell cycle regulators, and repressed estrogen-induced and G1-driven promotion of cell proliferation, suggesting that estrogen regulated cell proliferation of gMECs through mechanisms involving cell cycle, dependent of GPR30 and MEK/ERK and PI3K/AKT signaling pathway. This may provide a strong theoretical basis for researching estrogen sustained-release drugs promoting breast development and improving lactation performance.Abbreviations: gMECs, goat mammary epithelial cells; E2, 17β-estradiol; GPR30, G protein-coupled receptor 30; shRNA, small hairpin RNA; CDK, cyclin-dependent kinase; PI3K, phosphatidylinositol 3-kinase; AKT, proteinkinase B; MAPK, mitogen-activated protein kinase; MEK, mitogen-activated protein kinase kinase; ERK1/2, extracellular signal-regulated kinase 1/2.

Entities:  

Keywords:  Estrogen; G protein-coupled receptor 30; cell cycle; cell proliferation; goat mammary epithelial cells

Mesh:

Substances:

Year:  2022        PMID: 35659445      PMCID: PMC9467539          DOI: 10.1080/15384101.2022.2083708

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   5.173


  50 in total

1.  Nuclear estrogen receptor-mediated Notch signaling and GPR30-mediated PI3K/AKT signaling in the regulation of endometrial cancer cell proliferation.

Authors:  Yanan Wei; Zhenbo Zhang; Hong Liao; Ling Wu; Xiaomei Wu; Dongmei Zhou; Xiaowei Xi; Yaping Zhu; Youji Feng
Journal:  Oncol Rep       Date:  2011-11-08       Impact factor: 3.906

Review 2.  Anatomy of the human mammary gland: Current status of knowledge.

Authors:  Foteini Hassiotou; Donna Geddes
Journal:  Clin Anat       Date:  2012-09-19       Impact factor: 2.414

Review 3.  Twenty years of the G protein-coupled estrogen receptor GPER: Historical and personal perspectives.

Authors:  Matthias Barton; Edward J Filardo; Stephen J Lolait; Peter Thomas; Marcello Maggiolini; Eric R Prossnitz
Journal:  J Steroid Biochem Mol Biol       Date:  2017-03-25       Impact factor: 4.292

4.  The activation of the G protein-coupled estrogen receptor (GPER) inhibits the proliferation of mouse melanoma K1735-M2 cells.

Authors:  Mariana P C Ribeiro; Armanda E Santos; José B A Custódio
Journal:  Chem Biol Interact       Date:  2017-09-22       Impact factor: 5.192

5.  GPER mediates estrogen-induced signaling and proliferation in human breast epithelial cells and normal and malignant breast.

Authors:  Eric R Prossnitz; Helen J Hathaway; Allison L Scaling
Journal:  Horm Cancer       Date:  2014-04-10       Impact factor: 3.869

6.  Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF.

Authors:  E J Filardo; J A Quinn; K I Bland; A R Frackelton
Journal:  Mol Endocrinol       Date:  2000-10

7.  Identification of a GPER/GPR30 antagonist with improved estrogen receptor counterselectivity.

Authors:  Megan K Dennis; Angela S Field; Ritwik Burai; Chinnasamy Ramesh; Whitney K Petrie; Cristian G Bologa; Tudor I Oprea; Yuri Yamaguchi; Shin-Ichi Hayashi; Larry A Sklar; Helen J Hathaway; Jeffrey B Arterburn; Eric R Prossnitz
Journal:  J Steroid Biochem Mol Biol       Date:  2011-07-14       Impact factor: 4.292

Review 8.  The MEK/ERK Network as a Therapeutic Target in Human Cancer.

Authors:  Renee Barbosa; Lucila A Acevedo; Ronen Marmorstein
Journal:  Mol Cancer Res       Date:  2020-11-02       Impact factor: 6.333

9.  Estrogen Activation of G-Protein-Coupled Estrogen Receptor 1 Regulates Phosphoinositide 3-Kinase and mTOR Signaling to Promote Liver Growth in Zebrafish and Proliferation of Human Hepatocytes.

Authors:  Saireudee Chaturantabut; Arkadi Shwartz; Kimberley J Evason; Andrew G Cox; Kyle Labella; Arnout G Schepers; Song Yang; Mariana Acuña; Yariv Houvras; Liliana Mancio-Silva; Shannon Romano; Daniel A Gorelick; David E Cohen; Leonard I Zon; Sangeeta N Bhatia; Trista E North; Wolfram Goessling
Journal:  Gastroenterology       Date:  2019-01-12       Impact factor: 22.682

Review 10.  Amino acids and mammary gland development: nutritional implications for milk production and neonatal growth.

Authors:  Reza Rezaei; Zhenlong Wu; Yongqing Hou; Fuller W Bazer; Guoyao Wu
Journal:  J Anim Sci Biotechnol       Date:  2016-04-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.